AstraZeneca / BenevolentAI artificial intelligence collaboration will accelerate drug discovery Potential new drugs discovery in the area of chronic kidney…
New study combining Esbriet (pirfenidone) and nintedanib showing similar safety profile for the combination treatment to that expected for each…
61% of IPF patients are worried or extremely worried about experiencing an acute IPF exacerbation1 Survey underlines the importance of…